Timothé CYNOBER (Pharm D.)

Timothé Cynober is a Pharm D. professional with a diverse range of work experience. Timothé began their career as an intern at the Assistance publique-hôpitaux de Paris, where they gained experience in pharmacy, prescription follow-up, and training. Timothé then worked as a regulatory scientist at Voisin Consulting Life Sciences, providing support to clients in regulatory services for medicinal products and medical devices.

In 2014, Timothé completed a research internship in natural product chemistry at Paris-Sud University. Timothé then joined Labiotech.eu as a writer, focusing on topics such as biotech, cell therapies, AI, and oncology. From 2016 to 2020, Timothé worked at the Institut Curie as a business manager for tech transfer and industrial partnerships, primarily involving intellectual property strategy, business development, and licensing.

At Novartis, Timothé held multiple roles, including digital innovation manager at BIOME Paris, where they facilitated partnerships with the healthtech ecosystem and raised awareness of healthtech innovation. Timothé also served as a part-time rotation in the Value & Access department for the Europe region.

Currently, Timothé is working as a business development manager at WhiteLab Genomics, focusing on unleashing the potential of genomic therapies using artificial intelligence. Timothé'sresponsibilities include partnering with academics, biotech, and pharmaceutical companies to help cure more diseases at an affordable cost.

In addition, Timothé has served as a strategic board member at CITRAGE, contributing to creating a serene and healthy aging experience.

Overall, Timothé Cynober's work experience spans various sectors, including healthcare, pharmaceuticals, research, and business development, with a focus on innovative technologies and partnerships.

Timothé Cynober (Pharm D.) completed their education in the following chronological order:

From 2001 to 2007, Timothé attended Lakanal in Sceaux, where they obtained their Baccalauréat degree.

Timothé then enrolled at Université Paris-Saclay from 2008 to 2015, where they pursued a Bachelor of Pharmacy (B.Pharm.) degree with a focus on the industry.

In 2014 and 2015, Timothé continued their education at Université Paris-Saclay, completing their Master's degree (Master 2) in Biotechnology and Innovative Therapies.

In 2019, Timothé attended IEEPI, where they specialized in Intellectual Property and Technology Transfer Strategy for software.

These are the educational milestones in Timothé Cynober's academic journey.